City Cancer Challenge (C/Can) Foundation and The American Society of Clinical Oncology (ASCO) have joined forces in an effort to cultivate leadership in women in oncology to become agents of change through an initiative called: The Leadership Programme for Women in Oncology (LPWO)' - this is a unique opportunity for a mid-career oncologists based in Greater Petaling (Petaling Jaya, Subang Jaya, Shah Alam, Kuala Lumpur & Putrajaya) to represent the city and Malaysia in the programme'
The LPWO aims to prepare 10 mid-career women oncologists from C/Can cities to advance cancer treatment and care in LMICs by increasing leadership impact and creating lasting personal and professional change. This programme will foster the creation of a network of female leaders in cancer care who can pave the way for a new generation of women in cancer care.
The application opens from today until 13 June 2022 with the outcomes to be announced on 3 August 2022. Successful applicants will then take part in the programme from 17 October 2022 to 5 June 2023.
Do check out the 'what you need to know section' on the C/Can's webpage. Link here: https://sites.google.com/citycancerchallenge.org/leadership--women-oncology/home
Background: City Cancer Challenge Foundation is a Global Health Organisation based in Geneva, Switzerland. C/Can was launched by the Union for International Cancer Control (UICC) in 2017 at the World Economic Forum Annual Meeting in Davos. Since 2017, C/Can has partnered with cities across the globe to identify gaps in cancer care and to develop innovative, sustainable solutions, ensuring that no one is left behind in accessing the care they need. Greater Petaling (Malaysia) became the 9th city to join the C/Can Challenge in October 2019 with the MoU coming into effect in May 2021 (signed between C/Can Foundation, University of Malaya, National Cancer Society Malaysia, and the Selangor State represented by MBPJ, MBSJ, and MBSA) to kick start the C/Can’s City Engagement Process: an implementation framework whereby local stakeholders lead a staged city-wide process over a 2- to 3-year period to assess, plan, and execute locally adapted cancer care solutions.